MEIP Valuation

MEI Pharma Inc

Add to Watchlist

Advanced Chart

4.890

-0.01(-0.204%)1D

Overview
Forecast
Valuation
Earnings

MEIP Relative Valuation

MEIP's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MEIP is overvalued; if below, it's undervalued.

Historical Valuation

MEI Pharma Inc (MEIP) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.06. The fair price of MEI Pharma Inc (MEIP) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：4.89

Fair

-0.78

Trailing

Forward

0.00

EV/EBITDA

MEI Pharma Inc. (MEIP) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

-3.03

EV/EBIT

MEI Pharma Inc. (MEIP) has a current EV/EBIT of -3.03. The 5-year average EV/EBIT is -0.85. The thresholds are as follows: Strongly Undervalued below -6.04, Undervalued between -6.04 and -3.45, Fairly Valued between 1.75 and -3.45, Overvalued between 1.75 and 4.35, and Strongly Overvalued above 4.35. The current Forward EV/EBIT of -3.03 falls within the Historic Trend Line -Fairly Valued range.

0.00

MEI Pharma Inc. (MEIP) has a current PS of 0.00. The 5-year average PS is 47.47. The thresholds are as follows: Strongly Undervalued below -217.65, Undervalued between -217.65 and -85.09, Fairly Valued between 180.03 and -85.09, Overvalued between 180.03 and 312.59, and Strongly Overvalued above 312.59. The current Forward PS of 0.00 falls within the Historic Trend Line -Fairly Valued range.

-1.22

P/OCF

MEI Pharma Inc. (MEIP) has a current P/OCF of -1.22. The 5-year average P/OCF is 1.87. The thresholds are as follows: Strongly Undervalued below -30.61, Undervalued between -30.61 and -14.37, Fairly Valued between 18.11 and -14.37, Overvalued between 18.11 and 34.36, and Strongly Overvalued above 34.36. The current Forward P/OCF of -1.22 falls within the Historic Trend Line -Fairly Valued range.

-1.22

P/FCF

MEI Pharma Inc. (MEIP) has a current P/FCF of -1.22. The 5-year average P/FCF is -2.13. The thresholds are as follows: Strongly Undervalued below -8.23, Undervalued between -8.23 and -5.18, Fairly Valued between 0.92 and -5.18, Overvalued between 0.92 and 3.96, and Strongly Overvalued above 3.96. The current Forward P/FCF of -1.22 falls within the Historic Trend Line -Fairly Valued range.

MEI Pharma Inc (MEIP) has a current Price-to-Book (P/B) ratio of 1.67. Compared to its 3-year average P/B ratio of 0.88 , the current P/B ratio is approximately 88.82% higher. Relative to its 5-year average P/B ratio of 2.60, the current P/B ratio is about -35.81% higher. MEI Pharma Inc (MEIP) has a Forward Free Cash Flow (FCF) yield of approximately -22.94%. Compared to its 3-year average FCF yield of -177.41%, the current FCF yield is approximately -87.07% lower. Relative to its 5-year average FCF yield of -110.33% , the current FCF yield is about -79.21% lower.

1.67

P/B

Median3y

0.88

Median5y

2.60

-22.94

FCF Yield

Median3y

-177.41

Median5y

-110.33

Competitors Valuation Multiple

The average P/S ratio for MEIP's competitors is 39.46, providing a benchmark for relative valuation. MEI Pharma Inc Corp (MEIP) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Clearside Biomedical Inc

Onkure Therapeutics Inc

Performance Decomposition

Market capitalization of MEIP increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of MEIP in the past 1 year is driven by Unknown.